Australia markets closed

Prescient Therapeutics Limited (PTX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.04000.0000 (0.00%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Research development
7,817
6,222
3,400
2,495
2,760
Selling general and administrative
2,798
2,731
3,699
2,932
1,734
Total operating expenses
11,550
9,888
7,101
5,428
4,495
Operating income or loss
-11,550
-9,888
-7,101
-5,428
-4,495
Interest expense
4.19
-
6.534
10.615
4.19
Total other income/expenses net
3,105
2,422
1,944
1,223
1,107
Income before tax
-7,744
-7,005
-5,117
-4,149
-3,321
Income tax expense
0
0
0
0
0
Income from continuing operations
-7,744
-7,005
-5,117
-4,149
-3,321
Net income
-7,744
-7,005
-5,117
-4,149
-3,321
Net income available to common shareholders
-7,744
-7,005
-5,117
-4,149
-3,321
Basic EPS
-0.01
-0.01
-0.01
-0.01
-0.01
Diluted EPS
-0.01
-0.01
-0.01
-0.01
-0.01
Basic average shares
727,527
727,527
647,801
611,805
394,261
Diluted average shares
727,527
727,527
647,801
611,805
394,261